NM_016188.5(ACTL6B):c.556C>T (p.Gln186Ter)Pathogenic
Developmental and epileptic encephalopathy, 76|ACTL6B-related recessive epilepsy
β
β
ββ2025β Residue 186
NM_016188.5(ACTL6B):c.1027G>A (p.Gly343Arg)Pathogenic
Intellectual developmental disorder with severe speech and ambulation defects|Autism;ACTL6B-related dominant intellectual disability|Intellectual disability|ACTL6B-related BAFopathy|not provided|Inborn genetic diseases
β
β
ββ2025β Residue 343
NM_016188.5(ACTL6B):c.289C>T (p.Arg97Ter)Likely pathogenic
Developmental and epileptic encephalopathy, 76|ACTL6B-related recessive epilepsy|Intellectual developmental disorder with severe speech and ambulation defects
β
β
ββ2024β Residue 97
NM_016188.5(ACTL6B):c.740G>A (p.Trp247Ter)Likely pathogenic
Developmental and epileptic encephalopathy, 76|not provided|ACTL6B-related recessive epilepsy|ACTL6B-related disorder
β
β
ββ2021β Residue 247
NM_016188.5(ACTL6B):c.892C>T (p.Arg298Ter)Pathogenic
Autism spectrum disorder|not provided
β
βββ2025β Residue 298
NM_016188.5(ACTL6B):c.1111C>G (p.Pro371Ala)Likely pathogenic
not provided
β
βββ2025β Residue 371
NM_016188.5(ACTL6B):c.1112C>T (p.Pro371Leu)Likely pathogenic
not provided
β
βββ2025β Residue 371
NM_016188.5(ACTL6B):c.149del (p.Gly50fs)Pathogenic
Developmental and epileptic encephalopathy, 76
β
βββ2025β Residue 50
NM_016188.5(ACTL6B):c.990_993delinsAGCA (p.Gly331Ala)Likely pathogenic
Intellectual developmental disorder with severe speech and ambulation defects
β
βββ2025β Residue 331
NM_016188.5(ACTL6B):c.1113+1G>TLikely pathogenic
Congenital generalized lipodystrophy type 2
β
βββ2024
NM_016188.5(ACTL6B):c.604C>T (p.Gln202Ter)Pathogenic
Developmental and epileptic encephalopathy, 76
β
βββ2024β Residue 202
NM_016188.5(ACTL6B):c.370-2A>GLikely pathogenic
not provided
β
βββ2024
NM_016188.5(ACTL6B):c.1112C>G (p.Pro371Arg)Pathogenic
not provided
β
βββ2024β Residue 371
NM_016188.5(ACTL6B):c.37del (p.Ala13fs)Likely pathogenic
not provided
β
βββ2024β Residue 13
NM_016188.5(ACTL6B):c.1120C>T (p.Arg374Ter)Pathogenic
Developmental and epileptic encephalopathy, 76
β
βββ2024β Residue 374
NM_016188.5(ACTL6B):c.999T>A (p.Cys333Ter)Pathogenic
Developmental and epileptic encephalopathy, 76
β
βββ2024β Residue 333
NM_016188.5(ACTL6B):c.1121G>A (p.Arg374Gln)Likely pathogenic
not provided
β
βββ2022β Residue 374
NM_016188.5(ACTL6B):c.369+1G>CLikely pathogenic
Developmental and epileptic encephalopathy, 76
β
βββ2022
NM_016188.5(ACTL6B):c.1027G>T (p.Gly343Trp)Likely pathogenic
Intellectual developmental disorder with severe speech and ambulation defects
β
βββ2022β Residue 343
NM_016188.5(ACTL6B):c.554T>C (p.Leu185Pro)Likely pathogenic
Intellectual developmental disorder with severe speech and ambulation defects
β
βββ2022β Residue 185